CD44 and breast cancer: Bai et al. showed that the downregulation of hypoxia-inducible factor 2 alpha (HIF-2α) expression inhibits the stemness of BC cells and promotes apoptosis mediated by CD44/PI3 K/AKT/mTOR signaling pathway (Bai et al. 2020).